Arcellx, Inc. (ACLX)
115.07
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
Arcellx SG&A Expense (TTM) : 117.76M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 8.398B |
| Eli Lilly & Co. | 11.56B |
| Merck & Co., Inc. | 10.88B |
| Bristol Myers Squibb Co. | 7.30B |
| BioMarin Pharmaceutical, Inc. | 946.91M |